News

Medical Dialogues47m
Amycretin Shows Up to 24% Weight Loss in Early Trials, With Added Blood Sugar Benefits: Study
The investigational dual GLP-1 and amylin receptor agonist Amycretin demonstrated significant weight loss—up to 24% with ...